JCAM
NBP

Jericho Capital Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Jericho Capital Asset Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-149,000
Closed -$7.22M – 58
2021
Q1 		$7.22M Buy
+149,000
New +$8.08M 0.19% 49

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Jericho Capital Asset Management's NBP Position: Q2 2021 in Review

Jericho Capital Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2021, closing a stake of 149,000 shares — an estimated $7.22M sold.

Jericho Capital Asset Management first reported a position in NBP in Q1 2021 and held it in 1 quarter. The position peaked at $7.22M in Q1 2021. 136 funds tracked by Wall St. Rank hold NBP as of Q2 2021.

  • Jericho Capital Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Jericho Capital Asset Management sold 149,000 NovaBridge Biosciences American Depositary Shares shares in Q2 2021, an estimated $7.22M.
  • Jericho Capital Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Jericho Capital Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $7.22M in Q1 2021.
  • 136 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2021.

Based on Jericho Capital Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.